Table 1.
Characteristics of the prostate cancer patients underwent RP, 1998–2012
| Total |
|
|---|---|
| n = 406 (%) | |
| Median age, y | 62 |
| Median PSA | 6.9 |
| Median follow-up, mo | 108.9 |
| Adjuvant radiation therapy | 142 (35) |
| SPM patients | |
| n = 41 | |
| Median age at diagnosis, y | 66 |
| Median preoperative PSA | 4.62 |
| PSA failure | 11 (27) |
| Pathologic stage | |
| T2 | 27 (66) |
| T3 | 14 (34) |
| Gleason score | |
| 6 | 15 (37) |
| 3 + 4 | 19 (46) |
| > 8 | 7 (17) |
| D'amico characteristics | |
| Low risk Intermediate risk High risk |
14 (34%) 16 (39%) 11 (27%) |
| Adjuvant radiation therapy | 12 (29) |
PSA, prostate-specific antigen; RP, Radical prostatectomy; SPM, second primary malignancy.